TimesSquare Capital Management LLC Has $8.96 Million Holdings in Certara, Inc. (NASDAQ:CERT)

TimesSquare Capital Management LLC trimmed its position in shares of Certara, Inc. (NASDAQ:CERT) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 509,185 shares of the company’s stock after selling 9,890 shares during the quarter. TimesSquare Capital Management LLC’s holdings in Certara were worth $8,957,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also made changes to their positions in the stock. Motley Fool Asset Management LLC raised its stake in shares of Certara by 2.0% in the 3rd quarter. Motley Fool Asset Management LLC now owns 45,890 shares of the company’s stock valued at $667,000 after acquiring an additional 890 shares in the last quarter. Natixis Advisors L.P. boosted its stake in Certara by 13.4% in the 3rd quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock valued at $220,000 after buying an additional 1,791 shares in the last quarter. Truist Financial Corp boosted its stake in Certara by 20.5% in the 4th quarter. Truist Financial Corp now owns 13,958 shares of the company’s stock valued at $246,000 after buying an additional 2,372 shares in the last quarter. Swiss National Bank boosted its stake in Certara by 1.1% in the third quarter. Swiss National Bank now owns 263,600 shares of the company’s stock worth $3,833,000 after purchasing an additional 2,900 shares in the last quarter. Finally, Zions Bancorporation N.A. boosted its stake in Certara by 9.1% in the third quarter. Zions Bancorporation N.A. now owns 36,717 shares of the company’s stock worth $534,000 after purchasing an additional 3,054 shares in the last quarter. 73.96% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CERT shares. SVB Leerink started coverage on Certara in a research report on Monday, February 26th. They set a “market perform” rating and a $19.00 target price for the company. Leerink Partnrs restated a “market perform” rating on shares of Certara in a research report on Monday, February 26th. JMP Securities started coverage on Certara in a research report on Thursday, April 4th. They set a “market perform” rating for the company. KeyCorp upgraded Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a research report on Wednesday, April 10th. Finally, Jefferies Financial Group boosted their target price on Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research report on Friday, March 1st. Seven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Certara presently has an average rating of “Hold” and an average target price of $20.06.

Certara Stock Up 0.5 %

Certara stock traded up $0.09 during midday trading on Friday, reaching $17.15. The stock had a trading volume of 27,452 shares, compared to its average volume of 532,034. Certara, Inc. has a 1-year low of $11.81 and a 1-year high of $22.65. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.62 and a current ratio of 2.62. The firm’s fifty day simple moving average is $17.71 and its 200-day simple moving average is $16.45. The stock has a market capitalization of $2.75 billion, a P/E ratio of -48.74, a price-to-earnings-growth ratio of 1.81 and a beta of 1.61.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). The business had revenue of $88.01 million during the quarter, compared to the consensus estimate of $86.80 million. Certara had a positive return on equity of 4.33% and a negative net margin of 15.62%. As a group, analysts expect that Certara, Inc. will post 0.29 EPS for the current fiscal year.

Insider Buying and Selling

In other Certara news, insider Patrick F. Smith sold 14,427 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total transaction of $243,094.95. Following the transaction, the insider now owns 50,091 shares of the company’s stock, valued at $844,033.35. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, insider Patrick F. Smith sold 14,427 shares of Certara stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Richard M. Traynor sold 6,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $18.00, for a total transaction of $108,000.00. Following the transaction, the senior vice president now directly owns 165,368 shares in the company, valued at $2,976,624. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,427 shares of company stock worth $405,095. Corporate insiders own 2.39% of the company’s stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.